Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo M Horlings

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Breast Cancer Research and Treatment|November 26, 2010
Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinomaHermien Hartog, Hugo M Horlings, Bert van der Vegt, et al.
Nature Communications|October 6, 2015
Systematic analysis of somatic mutations impacting gene expression in 12 tumour typesJiarui Ding, Melissa K McConechy, Hugo M Horlings, et al.
Journal of the Endocrine Society|April 21, 2020
Functional Profiling of FSH and Estradiol in Ovarian Granulosa Cell TumorsUlla-Maija Haltia, Marjut Pihlajoki, Noora Andersson, et al.
JCO Precision Oncology|September 22, 2023
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide CohortTessa G Steenbruggen, Denise M Wolf, Bram Thijssen, et al.
Molecular Cancer Research : MCR|April 5, 2020
The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor-Positive Breast CancersIrida Kastrati, Stacey E P Joosten, Svetlana E Semina, et al.
Plos One|November 17, 2011
External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvementDavid Hajage, Yann de Rycke, Marc Bollet, et al.
Breast Cancer Research and Treatment|April 22, 2008
Molecular profiles of progesterone receptor loss in human breast tumorsChad J Creighton, C Kent Osborne, Marc J van de Vijver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patientsHugo M Horlings, Carmen Lai, Dimitry S A Nuyten, et al.
The American Journal of Surgical Pathology|November 18, 2025
Performance Assessment of a Deep Learning-based Algorithm for Ovarian Cancer Histotyping in an Independent Data SetHein S Zelisse, Maryam Asadi-Aghbolaghi, Hossein Farahani, et al.
Cancer Cell|October 16, 2007
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancerKatrien Berns, Hugo M Horlings, Bryan T Hennessy, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Breast Cancer Research and Treatment|November 26, 2010
Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinomaHermien Hartog, Hugo M Horlings, Bert van der Vegt, et al.
Nature Communications|October 6, 2015
Systematic analysis of somatic mutations impacting gene expression in 12 tumour typesJiarui Ding, Melissa K McConechy, Hugo M Horlings, et al.
Journal of the Endocrine Society|April 21, 2020
Functional Profiling of FSH and Estradiol in Ovarian Granulosa Cell TumorsUlla-Maija Haltia, Marjut Pihlajoki, Noora Andersson, et al.
JCO Precision Oncology|September 22, 2023
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide CohortTessa G Steenbruggen, Denise M Wolf, Bram Thijssen, et al.
Molecular Cancer Research : MCR|April 5, 2020
The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor-Positive Breast CancersIrida Kastrati, Stacey E P Joosten, Svetlana E Semina, et al.
Plos One|November 17, 2011
External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvementDavid Hajage, Yann de Rycke, Marc Bollet, et al.
Breast Cancer Research and Treatment|April 22, 2008
Molecular profiles of progesterone receptor loss in human breast tumorsChad J Creighton, C Kent Osborne, Marc J van de Vijver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patientsHugo M Horlings, Carmen Lai, Dimitry S A Nuyten, et al.
The American Journal of Surgical Pathology|November 18, 2025
Performance Assessment of a Deep Learning-based Algorithm for Ovarian Cancer Histotyping in an Independent Data SetHein S Zelisse, Maryam Asadi-Aghbolaghi, Hossein Farahani, et al.
Cancer Cell|October 16, 2007
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancerKatrien Berns, Hugo M Horlings, Bryan T Hennessy, et al.
Pageof 11